CSIMarket
 


Biodelivery Sciences International Inc   (BDSI)
Other Ticker:  
 

Biodelivery Sciences International Inc 's Total Debt to Equity

BDSI's quarterly Total Debt to Equity and Total Debt, Equity growth


Despite a net increase in borrowings by 0.13%, Biodelivery Sciences International Inc managed to enhance Total Debt to Equity in the forth quarter 2021 to 0.31, falling below the company's typical Total Debt to Equity.

Within Major Pharmaceutical Preparations industry in the forth quarter 2021, 119 other companies have achieved lower Total Debt to Equity than Biodelivery Sciences International Inc in the IV Quarter 2021. While Total Debt to Equity total ranking has improved so far in the forth quarter 2021 to 1387, from total ranking in the third quarter 2021 at 1574 .

Explain Debt to Equity Ratio?
What is the structure of BDSI´s Total Debt?
How valuable is the BDSI´s Equity?


BDSI Total Debt to Equity (Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
Y / Y Equity Change 73.53 % 28.04 % 34.38 % 42.13 % 55.14 %
Y / Y Total Debt Change -25.06 % -25.07 % 0.45 % 33.95 % 33.95 %
Total Debt to Equity MRQ 0.31 0.48 0.69 0.72 0.72
BDSI's Total Ranking # 1387 # 1574 # 1725 # 1968 # 1328
Seq. Equity Change 52.98 % 7.77 % 4.65 % 0.57 % 12.88 %
Seq. Total Debt Change 0.13 % -25.32 % 0.11 % 0.11 % 0.11 %



Total Debt to Equity forth quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 120
Healthcare Sector # 276
Overall Market # 1387


Total Debt to Equity Statistics
High Average Low
35.66 2.34 0.21
(Mar 31 2018)   (Mar 31 2015)




Financial Statements
Biodelivery Sciences International Inc 's Equity $ 188 Millions Visit BDSI's Balance sheet
Biodelivery Sciences International Inc 's Total Debt $ 59 Millions Visit BDSI's Balance sheet
Source of BDSI's Sales Visit BDSI's Sales by Geography


Cumulative Biodelivery Sciences International Inc 's Total Debt to Equity

BDSI's Total Debt to Equity for the trailling 12 Months

BDSI Total Debt to Equity

(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
Y / Y Equity TTM Growth 73.53 % 28.04 % 34.38 % 42.13 % 55.14 %
Y / Y Total Debt TTM Growth -25.06 % -25.07 % 0.45 % 33.95 % 33.95 %
Total Debt to Equity TTM 0.51 0.65 0.74 0.79 0.8
Total Ranking TTM # 178 # 237 # 217 # 1026 # 225
Seq. Equity TTM Growth 52.98 % 7.77 % 4.65 % 0.57 % 12.88 %
Seq. Total Debt TTM Growth 0.13 % -25.32 % 0.11 % 0.11 % 0.11 %


On the trailing twelve months basis Despite of the net new borrowings of 0.13% during the twelve months period ending in IV Quarter 2021 Biodelivery Sciences International Inc has managed to decrease Total Debt to Equity in the IV Quarter 2021 to 0.51, below Biodelivery Sciences International Inc 's average Total Debt to Equity.
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 32, during the past 12 months, other companies have achieved lower Total Debt to Equity than Biodelivery Sciences International Inc . While Total Debt to Equity total ranking has improved so far to 178, from total ranking in previous 12 month period at 237.

Explain Debt to Equity Ratio?
What is the structure of BDSI´s Total Debt?
How valuable is the BDSI´s Equity?

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 33
Healthcare Sector # 68
Within the Market # 178


trailing twelve months Total Debt to Equity Statistics
High Average Low
31.57 2.13 0.13
(Dec 31 2016)   (June 30. 2015)




Companies with similar Total Debt to Equity in the quarter ending Dec 31 2021, within Major Pharmaceutical Preparations Industry Total Debt to EquityDec 31 2021 MRQ Total DebtDec 31 2021 MRQ Equity
Ani Pharmaceuticals Inc  0.86 $ 287.370  Millions$ 333.890  Millions
Trevi Therapeutics Inc   0.85 $ 14.485  Millions$ 17.075  Millions
Elanco Animal Health Inc  0.84 $ 6,319.000  Millions$ 7,538.000  Millions
Aveo Pharmaceuticals Inc   0.83 $ 37.960  Millions$ 45.870  Millions
Obseva Sa  0.81 $ 26.324  Millions$ 32.339  Millions
Marinus Pharmaceuticals Inc   0.76 $ 40.809  Millions$ 53.486  Millions
Innoviva Inc   0.75 $ 394.653  Millions$ 525.935  Millions
Travere Therapeutics Inc   0.75 $ 226.581  Millions$ 302.112  Millions
Zealand Pharma A  0.72 $ 666.332  Millions$ 927.803  Millions
Assertio Holdings inc   0.72 $ 73.493  Millions$ 102.414  Millions
Scynexis Inc   0.70 $ 28.745  Millions$ 41.258  Millions
Royalty Pharma Plc  0.69 $ 7,096.070  Millions$ 10,248.545  Millions
Biovie Inc   0.69 $ 11.111  Millions$ 16.065  Millions
Perrigo Company Plc  0.68 $ 3,520.500  Millions$ 5,151.700  Millions
Rigel Pharmaceuticals Inc  0.66 $ 19.914  Millions$ 30.374  Millions
Baudax Bio Inc   0.65 $ 8.531  Millions$ 13.226  Millions
Cryoport inc   0.63 $ 405.257  Millions$ 641.828  Millions
Exicure Inc   0.61 $ 6.873  Millions$ 11.232  Millions
Ocular Therapeutix Inc   0.58 $ 51.435  Millions$ 87.999  Millions
Impel Pharmaceuticals Inc   0.56 $ 29.450  Millions$ 52.508  Millions
Kineta Inc   0.56 $ 13.162  Millions$ 23.497  Millions
Horizon Therapeutics Public Limited Company  0.55 $ 2,571.233  Millions$ 4,672.393  Millions
Chembio Diagnostics Inc   0.55 $ 18.789  Millions$ 34.265  Millions
Molecular Templates inc   0.54 $ 35.491  Millions$ 65.662  Millions
Aslan Pharmaceuticals Limited  0.54 $ 30.857  Millions$ 57.304  Millions
Adc Therapeutics Sa  0.52 $ 87.153  Millions$ 166.088  Millions
G1 Therapeutics Inc   0.52 $ 75.190  Millions$ 143.541  Millions
Emergent Biosolutions Inc   0.52 $ 841.000  Millions$ 1,619.000  Millions
Abbott Laboratories  0.50 $ 18,050.000  Millions$ 36,024.000  Millions
Pfizer Inc  0.50 $ 38,436.000  Millions$ 77,462.000  Millions

Date modified: 2023-03-23T19:06:47+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com